Aerocrine supplies instruments for nitric oxide (NO) measurements, a biological marker for airway inflammation. Measuring NO levels offers strong clinical benefits when diagnosing, monitoring and predicting exacerbations for asthma patients. Aerocrine’s products are world-leading for the routine measurement of the underlying inflammation in asthma. 
  • Sector: Healthcare
  • Status: Public (STOCKHOLM: AERO)
  • Geographic Market: Europe
  • Investment Year: 1999
  • Board Representation: Thomas Eklund

Visit the company’s website.